本文へスキップ

相互作用

Erdafitinib + Sevelamer

重症度: 中等度

Erdafitinib and Sevelamer: moderate interaction.

最終更新日

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

概要

Erdafitinib raises serum phosphate as an expected effect of FGFR inhibition, and this level guides dose escalation during the first weeks of treatment. A phosphate binder such as sevelamer can mask this rise and lead to inappropriate dosing decisions.

この相互作用をわかりやすく説明すると

Erdafitinib and Sevelamer can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erdafitinib belongs to Oncology; Sevelamer belongs to Miscellaneous.

エビデンスレベル: Moderate

なぜ起こるのか

Pharmacodynamic confounding: sevelamer binds dietary phosphate and lowers serum phosphate, obscuring the phosphate response used to titrate erdafitinib.

対処法

Avoid phosphate binders during the first 21 days of erdafitinib so the phosphate-guided dose titration is reliable. Afterward, use binders only if hyperphosphatemia needs management according to labeling.

薬剤師に尋ねること

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、ErdafitinibとSevelamerの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

WebでPro+を7日間無料でお試し。カード登録不要。

よくある質問

Can I take Erdafitinib with Sevelamer?

MediHelp rates the interaction as moderate. Erdafitinib and Sevelamer can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib raises serum phosphate as an expected effect of FGFR inhibition, and this level guides dose escalation during the first weeks of treatment. A phosphate binder such as sevelamer can mask this rise and lead to inappropriate dosing decisions.

How serious is the interaction between Erdafitinib and Sevelamer?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid phosphate binders during the first 21 days of erdafitinib so the phosphate-guided dose titration is reliable. Afterward, use binders only if hyperphosphatemia needs management according to labeling.

What other medicines interact with Sevelamer?

MediHelp also lists interactions of Sevelamer with, for example, Carbamazepine, Ciprofloxacin, Dichlorphenamide. The full list is on the Sevelamer page.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 相互作用

アプリを入手 ログイン